income and thus avoid conflicts of interest by task force and work group members. The full
disclosure of all income and research grants  from commercial sources, including the phar-
maceutical industry, in the previous 3 years, the imposition of an income cap from all com-
mercial sources, and the publication of disclosu res on a Web site set a new standard for the